FR2441625A1 - (d2-imidazolinyl-2 amino)-5 pyrimidines, procede pour les preparer, et medicaments qui en contiennent - Google Patents

(d2-imidazolinyl-2 amino)-5 pyrimidines, procede pour les preparer, et medicaments qui en contiennent

Info

Publication number
FR2441625A1
FR2441625A1 FR7928169A FR7928169A FR2441625A1 FR 2441625 A1 FR2441625 A1 FR 2441625A1 FR 7928169 A FR7928169 A FR 7928169A FR 7928169 A FR7928169 A FR 7928169A FR 2441625 A1 FR2441625 A1 FR 2441625A1
Authority
FR
France
Prior art keywords
imidazolinyl
pyrimidines
amino
medicinal products
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7928169A
Other languages
English (en)
Other versions
FR2441625B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2849537A external-priority patent/DE2849537C2/de
Priority claimed from DE19792937023 external-priority patent/DE2937023A1/de
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Publication of FR2441625A1 publication Critical patent/FR2441625A1/fr
Application granted granted Critical
Publication of FR2441625B1 publication Critical patent/FR2441625B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NOUVELLES (D-IMIDAZOLINYL-2 AMINO)-5 PYRIMIDINES. ELLES REPONDENT A LA FORMULE: (CF DESSIN DANS BOPI) DANS LAQUELLE R, R ET R REPRESENTENT CHACUN, INDEPENDAMMENT LES UNS DES AUTRES, UN ATOME D'HYDROGENE OU D'HALOGENE, UN RADICAL ALCOXY, ALKYLTHIO OU ALKYLE EN C-C OU UN RADICAL CYCLOALKYLE EN C-C, ET R REPRESENTE UN ATOME D'HYDROGENE OU UN RADICAL ACYLE ALIPHATIQUE OU AROMATIQUE. CES COMPOSES, A L'ETAT DE BASES LIBRES OU DE SELS, PEUVENT ETRE UTILISES COMME SUBSTANCES ACTIVES DE MEDICAMENTS DESTINES NOTAMMENT AU TRAITEMENT DE L'HYPERTENSION OU DU GLAUCOME.
FR7928169A 1978-11-15 1979-11-15 (d2-imidazolinyl-2 amino)-5 pyrimidines, procede pour les preparer, et medicaments qui en contiennent Granted FR2441625A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2849537A DE2849537C2 (de) 1978-11-15 1978-11-15 Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19792937023 DE2937023A1 (de) 1979-09-13 1979-09-13 Neue substituierte 5-(2-imidazolin-2-yl)-aminopyrimidine und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
FR2441625A1 true FR2441625A1 (fr) 1980-06-13
FR2441625B1 FR2441625B1 (fr) 1981-12-31

Family

ID=25776489

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7928169A Granted FR2441625A1 (fr) 1978-11-15 1979-11-15 (d2-imidazolinyl-2 amino)-5 pyrimidines, procede pour les preparer, et medicaments qui en contiennent

Country Status (12)

Country Link
US (1) US4323570A (fr)
AT (1) AT374197B (fr)
AU (1) AU541305B1 (fr)
CA (1) CA1138454A (fr)
CH (1) CH642965A5 (fr)
DK (1) DK150142C (fr)
ES (1) ES486349A1 (fr)
FR (1) FR2441625A1 (fr)
GB (1) GB2039275B (fr)
IT (1) IT1127225B (fr)
NL (2) NL190553C (fr)
SE (1) SE440079B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046241A1 (fr) * 1996-06-06 1997-12-11 Eli Lilly And Company Formulation et methode pour traiter l'insuffisance cardiaque congestive

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2146986B (en) * 1983-09-23 1987-06-17 Lilly Co Eli Process for preparing 5-substituted pyrimidines
DE3729299A1 (de) * 1987-09-02 1989-03-23 Beiersdorf Ag Transdermales therapeutisches system
DE3739779A1 (de) * 1987-11-24 1989-06-08 Beiersdorf Ag Pharmazeutische praeparate
DE3904795C2 (de) * 1989-02-17 2000-10-12 Lilly Pharma Produktion Gmbh & Pharmazeutisches Präparat und dessen Verwendung
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel
US5972948A (en) * 1994-07-01 1999-10-26 Solvay Pharmaceuticals Gmbh Method of inhibiting hyperglycemia and pharmaceutical composition for use therein
KR19980702511A (ko) * 1995-02-28 1998-07-15 크라우더 티 알 아테롬성 동맥경화증을 치료하기 위한 목소니딘의 용도
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
IL118544A (en) * 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
CA2182851A1 (fr) * 1995-08-15 1997-02-16 August Masaru Watanabe Methode de traitement d'un etat resultant de l'arret de la consommation abusive de drogues
IL123232A0 (en) * 1997-02-11 1999-11-30 Lilly Co Eli Medicament for inhibiting glucose metabolism deterioration
DE19722322A1 (de) * 1997-05-28 1998-12-03 Solvay Pharm Gmbh Nephroprotektives Arzneimittel
AU9302298A (en) * 1997-09-03 1999-03-22 Eli Lilly And Company Pyrimidine derivatives
DE19911371A1 (de) 1999-03-15 2000-09-21 Solvay Pharm Gmbh Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen
EP1517688A2 (fr) * 2002-06-19 2005-03-30 Solvay Pharmaceuticals GmbH Medicament pour traiter des affections impliquant une inhibition ou une baisse d'activite de proteines transporteuses de bicarbonate regulant le ph
WO2007090720A2 (fr) * 2006-01-27 2007-08-16 F. Hoffmann-La Roche Ag Utilisation de 2-imidazoles pour le traitement de troubles du système nerveux central
ATE520685T1 (de) 2006-06-26 2011-09-15 Chemagis Ltd Verbessertes verfahren zur herstellung von moxonidin
ES2315967T3 (es) * 2006-06-26 2009-04-01 Chemagis Ltd. Nuevo procedimiento de purificacion de moxonidina.
EP1894926A1 (fr) * 2006-06-26 2008-03-05 Chemagis Ltd. Substances polymorphes de moxonidine et procédés de leur préparation
WO2008020425A1 (fr) * 2006-08-17 2008-02-21 Chemagis Ltd. Moxonidine cristalline contenant un tautomère unique et son procédé de préparation
ATE487712T1 (de) * 2006-08-31 2010-11-15 Chemagis Ltd Verwendung der monoxidinssalze zur reinigung von monoxidin
EP2076496B1 (fr) * 2006-10-19 2010-03-31 F. Hoffmann-Roche AG Aminométhyl- 2 -imidazoles à affinité avec les récepteurs associés à une amine à l'état de trace
AU2007312390B2 (en) * 2006-10-19 2013-03-28 F. Hoffmann-La Roche Ag Aminomethyl-4-imidazoles
CN101535292A (zh) * 2006-11-02 2009-09-16 弗·哈夫曼-拉罗切有限公司 作为痕量胺相关受体的调节剂的取代的2-咪唑类化合物
CA2669112A1 (fr) * 2006-11-16 2008-05-22 F. Hoffmann-La Roche Ag 4-imidazoles substitues
WO2008073125A1 (fr) * 2006-12-12 2008-06-19 Chemagis Ltd. Analogues de la moxonidine, procédés de préparation et utilisations de ceux-ci
CN101557810B (zh) * 2006-12-13 2012-11-21 弗·哈夫曼-拉罗切有限公司 作为痕量胺相关受体（taar）的配体的新的2-咪唑类
US20080146523A1 (en) * 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
MX2009008255A (es) * 2007-02-02 2009-08-12 Hoffmann La Roche Nuevas 2-aminooxazolinas como ligandos taar1.
CA2676944C (fr) * 2007-02-15 2016-01-19 F. Hoffmann-La Roche Ag 2-aminooxazolines comme ligands de taar1
JP2010531837A (ja) 2007-07-02 2010-09-30 エフ．ホフマン−ラ ロシュ アーゲー 微量アミン関連レセプター（ｔａａｒ）に対して良好な親和性を有する２−イミダゾリン
CA2691704A1 (fr) * 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines et leur utilisation comme antidepresseurs
AU2008281918A1 (en) * 2007-07-27 2009-02-05 F. Hoffmann-La Roche Ag 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as TAAR-ligands
KR20100039429A (ko) * 2007-08-02 2010-04-15 에프. 호프만-라 로슈 아게 Ｃｎｓ 질환의 치료를 위한 벤즈아미드 유도체의 용도
CN101784515A (zh) * 2007-08-03 2010-07-21 弗·哈夫曼-拉罗切有限公司 作为taar1配体的吡啶甲酰胺和苯甲酰胺衍生物
KR101307007B1 (ko) * 2008-07-24 2013-09-11 에프. 호프만-라 로슈 아게 4,5-다이하이드로-옥사졸-2-일 유도체
US8242153B2 (en) * 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US20100311798A1 (en) * 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US8354441B2 (en) * 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
EP2586779A1 (fr) 2011-10-24 2013-05-01 Hetero Research Foundation Procédé pour la préparation de moxonidine
DE102012215896A1 (de) 2012-09-07 2014-03-13 Wörwag Pharma GmbH & Co.KG Moxonidinsynthese mit Hilfe organischer Basen
ES2608004T3 (es) 2012-12-03 2017-04-05 WÖRWAG PHARMA GmbH & Co. KG Método mediante catálisis por transferencia de fase
EP2765131B1 (fr) 2013-02-08 2016-11-23 Arevipharma GmbH Procédé de production de monoxidine
CN105121431A (zh) * 2013-03-14 2015-12-02 法尔马克有限公司 用于制造莫索尼定的改进方法
EP2829540A1 (fr) 2013-07-26 2015-01-28 Abbott Healthcare Products B.V. Synthèse d'aminopyridines substituées
KR102456567B1 (ko) 2013-08-09 2022-10-19 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
BR112018015389B1 (pt) 2016-03-17 2023-12-19 F. Hoffmann-La Roche Ag Derivado de 5-etil-4-metil-pirazol-3-carboxamida, seu processo de fabricação, preparação farmacêutica oral e uso
WO2022101435A1 (fr) 2020-11-12 2022-05-19 3Z Ehf Nouveaux traitements du trouble du déficit de l'attention/hyperactivité

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754832A (fr) 1969-08-14 1971-02-15 Beecham Group Ltd Iminazolines
GB1319840A (en) * 1970-08-27 1973-06-13 Beecham Group Ltd Substituted 5-amino imidazoles
BE795636A (fr) * 1972-02-19 1973-08-20 Schering Ag Nitroimidazolylpyrimidines, et leur procede de preparation
US4029792A (en) * 1972-02-29 1977-06-14 Pfizer Inc. (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents
DE2220906A1 (de) * 1972-04-28 1973-11-15 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung
BE503170A (fr) * 1975-09-02

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046241A1 (fr) * 1996-06-06 1997-12-11 Eli Lilly And Company Formulation et methode pour traiter l'insuffisance cardiaque congestive

Also Published As

Publication number Publication date
DK481879A (da) 1980-05-16
US4323570A (en) 1982-04-06
CH642965A5 (de) 1984-05-15
AU541305B1 (en) 1985-01-03
SE7909392L (sv) 1980-05-16
NL940011I1 (nl) 1994-08-01
SE440079B (sv) 1985-07-15
NL7908192A (nl) 1980-05-19
GB2039275A (en) 1980-08-06
IT7927284A0 (it) 1979-11-14
CA1138454A (fr) 1982-12-28
NL190553B (nl) 1993-11-16
AT374197B (de) 1984-03-26
IT1127225B (it) 1986-05-21
DK150142C (da) 1987-06-01
NL190553C (nl) 1994-04-18
GB2039275B (en) 1982-11-17
DK150142B (da) 1986-12-15
ES486349A1 (es) 1980-06-16
ATA727079A (de) 1983-08-15
NL940011I2 (nl) 1998-05-06
FR2441625B1 (fr) 1981-12-31

Similar Documents

Publication Publication Date Title
FR2441625A1 (fr) (d2-imidazolinyl-2 amino)-5 pyrimidines, procede pour les preparer, et medicaments qui en contiennent
DK420385A (da) Antioestrogent laegemiddel til perkutan indgift
FR2439182A1 (fr) Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments
LU90949I2 (fr) Esters aminoalcohol d'acide thienylcarboxyliques leurs produits quaternaires leur préparation et l'utilisation de ces composés
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
FR2397403A1 (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
FR2469411A1 (fr) Nouveaux derives de la piperidylbenzimidazolinone, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
FR2447376A1 (fr) Nouveaux derives de 1,2-dihydro-2-oxo-4-phenyl-3-quinoleinecarbonitrile, utiles notamment comme agents anti-inflammatoires
FR2394546A1 (fr) Nouveaux derives de 1,2,3,4,6,7-hexahydro-11bah-benzo(a)-quinolizine, leur preparation et leur application en tant que medicaments
FR2374317A1 (fr) Derives d'acide n-(benzothiazolyl-2)oxamique et procede pour leur preparation et leur utilisation comme medicament anti-allergique
FR2456104A1 (fr) Nouvelles pyrazinobenzodiazepines, leur preparation et leur application comme medicaments
FR2450820A1 (fr) Nouveaux derives d'acides 1- (o-mercaptoacyl) -4,5-dihydropyrazole-5-carboxyliques, utiles notamment comme agents hypotenseurs, et leur procede de preparation
FR2367750A1 (fr) Acid
FR2363608A1 (fr) Procede de preparation de colorants " bisazoiques "
FR2455587A1 (fr) Derives de benzimidazole, leur preparation et utilisation dans le traitement des affections cardiovasculaires et compositions les contenant
ES2001774A6 (es) Procedimiento para la preparacion de nuevos pirrolo-bencimidazoles, pirrolo-benzoxazoles y pirrolo-benzotiazoles.
FR2432520A1 (fr) Nouvelles imidazoquinoxalines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
LU81056A1 (fr) Medicament sous la forme d'une solution aqueuse sterile stable de cisplatine
ES2028838T3 (es) Procedimiento para la obtencion de nuevos derivados de 4,5-hidro-oxazoles.
DE3063525D1 (en) Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them
ATE40793T1 (de) Pharmazeutisches praeparat zur therapeutischen behandlung von rheumatischen erkrankungen.
BE1000245A3 (fr) Nouveaux derives de la purine, leur preparation et leur utilisation comme medicaments.
PT84399B (en) Process for the preparation of pharmaceutical compositions containing sodium 2-(2,6-dichloroanilino) phenylacetate
FR2439772A1 (fr) Procede de preparation d'urees et de thiourees utiles pour le traitement des ulceres gastrointestinaux et produits obtenus
FR2413358A1 (fr) Nouveaux derives de 2-aminomethylphenol, utiles notamment comme agents anti-inflammatoires, et leur procede de preparation

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name
CP Supplementary protection certificate (spc) filed

Free format text: PRODUCT NAME: MOXONIDINE; NAT. REGISTRATION NO/DATE: NL 18307 19940919; FIRST REGISTRATION: DE - 99530200 19910123

Spc suppl protection certif: 94C0021

Filing date: 19941103

CP Supplementary protection certificate (spc) filed

Free format text: 95C0021, 941103

CR Request for supplementary protection certificate laid open to the public (eec regulation of 18 june 1992)

Free format text: 95C0021, 941103

CP Supplementary protection certificate (spc) filed
CY Supplementary certificate of protection granted (eec regulation of 18 june 1992)

Free format text: 94C0021, 941103, EXPIRES:20041114

CP Supplementary protection certificate (spc) filed